Unknown

Dataset Information

0

Development and Internal Validation of a Web-based Tool to Predict Sexual, Urinary, and Bowel Function Longitudinally After Radiation Therapy, Surgery, or Observation.


ABSTRACT:

Background

Shared decision making to guide treatment of localized prostate cancer requires delivery of the anticipated quality of life (QOL) outcomes of contemporary treatment options (including radical prostatectomy [RP], intensity-modulated radiation therapy [RT], and active surveillance [AS]). Predicting these QOL outcomes based on personalized features is necessary.

Objective

To create an easy-to-use tool to predict personalized sexual, urinary, bowel, and hormonal function outcomes after RP, RT, and AS.

Design, setting, and participants

A prospective, population-based cohort study was conducted utilizing US cancer registries of 2563 men diagnosed with localized prostate cancer in 2011-2012.

Intervention

Patient-reported urinary, sexual, and bowel function up to 5 yr after treatment.

Outcome measurements and statistical analysis

Patient-reported urinary, sexual, bowel, and hormonal function through 5 yr after treatment were collected using the 26-item Expanded Prostate Index Composite (EPIC-26) questionnaire. Comprehensive models to predict domain scores were fit, which included age, race, D'Amico classification, body mass index, EPIC-26 baseline function, treatment, and standardized scores measuring comorbidity, general QOL, and psychosocial health. We reduced these models by removing the instrument scores and replacing D'Amico classification with prostate-specific antigen (PSA) and Gleason score. For the final model, we performed bootstrap internal validation to assess model calibration from which an easy-to-use web-based tool was developed.

Results and limitations

The prediction models achieved bias-corrected R-squared values of 0.386, 0.232, 0.183, 0.214, and 0.309 for sexual function, urinary incontinence, urinary irritative, bowel, and hormonal domains, respectively. Differences in R-squared values between the comprehensive and parsimonious models were small in magnitude. Calibration was excellent. The web-based tool is available at https://statez.shinyapps.io/PCDSPred/.

Conclusions

Functional outcomes after treatment for localized prostate cancer can be predicted at the time of diagnosis based on age, race, PSA, biopsy grade, baseline function, and a general question regarding overall health. Providers and patients can use this prediction tool to inform shared decision making.

Patient summary

In this report, we studied patient-reported sexual, urinary, hormonal, and bowel function through 5 yr after treatment with radical prostatectomy, radiation therapy, or active surveillance for localized prostate cancer. We developed a web-based predictive tool that can be used to predict one's outcomes after treatment based on age, race, prostate-specific antigen, biopsy grade, pretreatment baseline function, and a general question regarding overall health. We hope both patients and providers can use this tool to better understand expected outcomes after treatment, further enhancing shared decision making between providers and patients.

SUBMITTER: Laviana AA 

PROVIDER: S-EPMC7384934 | biostudies-literature | 2020 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Development and Internal Validation of a Web-based Tool to Predict Sexual, Urinary, and Bowel Function Longitudinally After Radiation Therapy, Surgery, or Observation.

Laviana Aaron A AA   Zhao Zhiguo Z   Huang Li-Ching LC   Koyama Tatsuki T   Conwill Ralph R   Hoffman Karen K   Goodman Michael M   Hamilton Ann S AS   Wu Xiao-Cheng XC   Paddock Lisa E LE   Stroup Antoinette A   Cooperberg Matthew R MR   Hashibe Mia M   O'Neil Brock B BB   Kaplan Sherrie H SH   Greenfield Sheldon S   Penson David F DF   Barocas Daniel A DA  

European urology 20200222 2


<h4>Background</h4>Shared decision making to guide treatment of localized prostate cancer requires delivery of the anticipated quality of life (QOL) outcomes of contemporary treatment options (including radical prostatectomy [RP], intensity-modulated radiation therapy [RT], and active surveillance [AS]). Predicting these QOL outcomes based on personalized features is necessary.<h4>Objective</h4>To create an easy-to-use tool to predict personalized sexual, urinary, bowel, and hormonal function ou  ...[more]

Similar Datasets

| S-EPMC6220963 | biostudies-literature
| S-EPMC5536350 | biostudies-literature
| S-EPMC11899208 | biostudies-literature
| S-EPMC5615455 | biostudies-literature
| S-EPMC9921108 | biostudies-literature
2012-09-06 | E-GEOD-40640 | biostudies-arrayexpress
2012-09-06 | GSE40640 | GEO
| S-EPMC6179951 | biostudies-literature
2024-03-24 | GSE228266 | GEO
| S-EPMC7067806 | biostudies-literature